Telegram
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиChinook Therapeutics Мультипликаторы 2011-2024 | KDNY
Мультипликаторы по годам Chinook Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-7.4 | -7.2 | -2.6 | - | - | - | - | - | - | - | - | - |
P/S |
227.3 | 14.4 | 252.5 | - | - | - | - | - | - | - | - | - |
EPS |
-2.9 | -2.3 | -6.2 | -25.5 | -1.2 | -1.3 | -1.4 | -0.9 | -53.1 | -55.8 | - | - |
EV (Enterprise Value) |
1.41 млрд | 672 млн | 115 млн | 166 млн | -126 млн | -158 млн | -74.9 млн | -150 млн | -119 млн | -8.53 млн | - | - |
EBITDA per Share |
-2.82 | -2.1 | -4.19 | - | - | - | - | - | - | - | - | - |
EV/EBITDA |
-6.9 | -1.4 | - | - | - | - | - | - | - | - | - | |
PEG |
- | 3.05 | - | - | - | - | - | - | - | - | - | |
P/B |
3.2 | 1.6 | 0.6 | - | - | - | - | - | - | - | - | - |
P/CF |
-11.9 | -7.2 | -3.7 | - | - | - | - | - | - | - | - | - |
ROE % |
-42.51 | -22.69 | -24.39 | - | - | - | - | - | - | - | - | - |
ROA % |
-32.72 | -18.26 | -19.03 | - | - | - | - | - | - | - | - | - |
ROCE % |
-41.88 | -21.83 | -16.80 | - | - | - | - | - | - | - | - | - |
Current Ratio |
4.3 | 5.1 | 4.5 | - | - | - | - | - | - | - | - | - |
DSO |
- | - | 75.5 | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | 75.5 | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | 75.5 | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Chinook Therapeutics
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.94 | -0.85 | - | -0.83 | -0.61 | -0.54 | - | -0.69 | -0.97 | -0.88 | - | -4.5 | -1.87 | -1.25 | -0.24 | -0.26 | -0.23 | -0.29 | -0.33 | -0.29 | -0.31 | -0.28 | -0.34 | -0.33 | -0.27 | -0.32 | -0.44 | -0.54 | 0.04 | -0.45 | 0.05 | 0.01 | -0.5 | -39.97 | -2.54 | -14.24 | -12.27 | -26.34 | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.99 | -0.86 | - | -0.84 | -0.58 | -0.51 | - | -0.68 | -0.97 | -0.86 | - | -2.17 | -1.56 | -0.69 | - | -1.46 | -0.24 | -0.3 | - | -0.3 | -0.3 | -0.28 | - | -0.36 | -0.32 | -0.36 | - | -0.36 | 0.06 | -0.4 | - | 0.01 | -0.18 | -17.3 | - | -16.1 | -22 | -20.5 | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-56.93 | -45.60 | -26.64 | -38.02 | -37.60 | -44.53 | -38.11 | -43.73 | -37.98 | -25.94 | -9.48 | 37.74 | 11.42 | -14.59 | -48.76 | 3768.93 | 3783.76 | 3794.05 | 3813.88 | -62.02 | -55.24 | -45.38 | -38.68 | -40.69 | -45.79 | -36.61 | -40.11 | -25.92 | -10.27 | -21.32 | -14.99 | -14.67 | -7.25 | 8.71 | 27.76 | 26.26 | 18.61 | 12.70 | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-43.72 | -36.29 | -21.71 | -29.72 | -28.24 | -32.42 | -27.78 | -32.16 | -28.54 | -19.91 | -7.39 | -130.88 | -133.69 | -138.26 | -145.10 | -28.97 | -28.26 | -28.70 | -26.67 | -25.18 | -24.22 | -21.75 | -20.64 | -21.51 | -23.99 | -19.11 | -20.78 | -13.40 | -5.29 | -11.26 | -8.14 | -9.51 | -13.33 | -10.75 | -13.45 | -12.73 | -9.02 | -6.16 | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-59.54 | -46.43 | -26.61 | -38.10 | -37.44 | -44.79 | -38.44 | -41.57 | -33.20 | -20.94 | -6.67 | -44.08 | -78.35 | -106.69 | -106.04 | -124.45 | -105.45 | -93.83 | -54.21 | -66.54 | -60.45 | -51.49 | -33.00 | -43.54 | -41.76 | -30.26 | -20.56 | -20.40 | -9.70 | -14.78 | -6.26 | 2.47 | 11.04 | 25.37 | 29.35 | 29.35 | 20.62 | 9.93 | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
3.7 | 4.1 | 4.3 | 5.1 | 6.4 | 5.1 | 5.1 | 3.4 | 3.7 | 4.1 | 4.5 | 4.5 | 4.5 | 4.5 | 0.4 | 1.3 | 1.3 | 1.3 | 1.6 | 1.6 | 1.6 | 1.6 | 2.1 | 2.1 | 2.1 | 2.1 | 2.1 | 2.1 | 2.1 | 2.1 | 2.2 | 2.2 | 2.2 | 2.2 | 2.6 | 2.6 | 2.6 | 2.6 | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | 34.1 | - | 28.7 | 18.2 | 4.6 | 7.1 | 5.4 | 6.4 | 143.4 | 398.2 | 358.6 | 416.2 | 89.7 | 24.0 | 23.8 | 15.2 | 25.7 | 26.8 | 27.4 | 2.7 | 67.8 | 12.9 | 23.1 | 44.7 | 38.1 | 29.1 | 115.7 | 292.1 | 5754.2 | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | 34.1 | - | 28.7 | 18.2 | 4.6 | 7.1 | 5.4 | 6.4 | 143.4 | 398.2 | 358.6 | 416.2 | 89.7 | 24.0 | 23.8 | 15.2 | 25.7 | 26.8 | 27.4 | 2.7 | 67.8 | 12.9 | 23.1 | 44.7 | 38.1 | 29.1 | 115.7 | 292.1 | 5754.2 | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | 34.1 | - | 28.7 | 18.2 | 4.6 | 7.1 | 5.4 | 6.4 | 143.4 | 398.2 | 358.6 | 416.2 | 89.7 | 24.0 | 23.8 | 15.2 | 25.7 | 26.8 | 27.4 | 2.7 | 67.8 | 12.9 | 23.1 | 44.7 | 38.1 | 29.1 | 115.7 | 292.1 | 5754.2 | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD